Ribatti D - Search Results

1

Broad targeting of angiogenesis for cancer prevention and therapy.

Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD. Wang Z, et al. Among authors: ribatti d. Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S224-S243. doi: 10.1016/j.semcancer.2015.01.001. Epub 2015 Jan 16. Semin Cancer Biol. 2015. PMID: 25600295 Free PMC article. Review.

2

Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor.

Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S, Dammacco F. Vacca A, et al. Among authors: ribatti d. Cancer. 1993 Jul 15;72(2):455-61. doi: 10.1002/1097-0142(19930715)72:2<455::aid-cncr2820720222>3.0.co;2-8. Cancer. 1993. PMID: 7686442

3

Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A.

Vacca A, Bruno M, Boccarelli A, Coluccia M, Ribatti D, Bergamo A, Garbisa S, Sartor L, Sava G. Vacca A, et al. Among authors: ribatti d. Br J Cancer. 2002 Mar 18;86(6):993-8. doi: 10.1038/sj.bjc.6600176. Br J Cancer. 2002. PMID: 11953835 Free PMC article.

4

Crosstalk between angiogenesis and lymphangiogenesis in tumor progression.

Scavelli C, Vacca A, Di Pietro G, Dammacco F, Ribatti D. Scavelli C, et al. Among authors: ribatti d. Leukemia. 2004 Jun;18(6):1054-8. doi: 10.1038/sj.leu.2403355. Leukemia. 2004. PMID: 15057248 Review.

5

Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases.

Ranieri G, Ria R, Roccaro AM, Vacca A, Ribatti D. Ranieri G, et al. Among authors: ribatti d. Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):13-22. doi: 10.2174/1568010053622966. Curr Drug Targets Inflamm Allergy. 2005. PMID: 15720230 Review.

6

Bone marrow angiogenesis in multiple myeloma.

Vacca A, Ribatti D. Vacca A, et al. Among authors: ribatti d. Leukemia. 2006 Feb;20(2):193-9. doi: 10.1038/sj.leu.2404067. Leukemia. 2006. PMID: 16357836 Review.

7

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.

Ranieri G, Patruno R, Ruggieri E, Montemurro S, Valerio P, Ribatti D. Ranieri G, et al. Among authors: ribatti d. Curr Med Chem. 2006;13(16):1845-57. doi: 10.2174/092986706777585059. Curr Med Chem. 2006. PMID: 16842197 Review.

8

Aquaporins in tumor growth and angiogenesis.

Nico B, Ribatti D. Nico B, et al. Among authors: ribatti d. Cancer Lett. 2010 Aug 28;294(2):135-8. doi: 10.1016/j.canlet.2010.02.005. Epub 2010 Mar 2. Cancer Lett. 2010. PMID: 20199845 Review.

9

Thyroid hormone as a regulator of tumor induced angiogenesis.

Pinto M, Soares P, Ribatti D. Pinto M, et al. Among authors: ribatti d. Cancer Lett. 2011 Feb 28;301(2):119-26. doi: 10.1016/j.canlet.2010.11.011. Epub 2010 Dec 22. Cancer Lett. 2011. PMID: 21183275 Review.

10

Mast cells, angiogenesis and cancer.

Ribatti D, Crivellato E. Ribatti D, et al. Adv Exp Med Biol. 2011;716:270-88. doi: 10.1007/978-1-4419-9533-9_14. Adv Exp Med Biol. 2011. PMID: 21713661 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

908 results

Search Page